Related Experiment Video
Updated: Aug 10, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc
M Reincke1, F Beuschlein, A C Latronico
1Department of Internal Medicine, University of Würzburg, FRG.
Objective:
Adrenocorticotrophin (ACTH) is the main hormone-regulating steroid secretion from the adrenal cortex. The ACTH receptor (ACTH-R) has recently been cloned, allowing systematic evaluation of its expression and function in adrenal tumorigenesis. We investigated ACTH-R and P450 side-chain cleavage enzyme (P450scc) mRNA expression in a variety of neoplastic adrenocortical tissues by Northern blot and reverse-transcriptase-PCR (RT-PCR).
Patients And Measurements:
We studied tissue from eight normal adrenals, six diffuse adrenocortical hyperplasias in patients with ACTH-dependent Cushing's syndrome, 22 adrenal adenomas, six carcinomas and two carcinoma cell lines. Poly A mRNA was electrophoresed, immobilized on a nylon membrane and hybridized using alpha 32P-CTP labelled human ACTH-R and P450scc cDNAs.
Results:
Mean ACTH-R mRNA expression showed significant differences between groups (P = 0.0001), but appeared to be independent of plasma ACTH concentrations. Compared to normal adrenal (= 100 +/- 12%), expression was low in non-functional adenomas (23 +/- 11%) and carcinomas (19 +/- 12%), intermediate in adrenocortical hyperplasias (88 +/- 6%) and cortisol-producing adenomas (81 +/- 15%) and high in aldosteronomas (175 +/- 29%). In adenomas, ACTH-R mRNA expression correlated closely with the expression of P450scc mRNA(r = 0.8, P = 0.0001) suggesting regulation by similar factors. However, carcinomas and cancer cell lines did not show a positive correlation between these two parameters (r = -0.44, P = 0.3).
Conclusions:
We have demonstrated that plasma ACTH is not the major factor influencing ACTH-receptor mRNA expression in neoplastic adrenal tissue. In benign tumours of the adrenal cortex there was a close positive correlation between ACTH-receptor mRNA and P450scc mRNA which was missing in adrenocortical carcinomas, probably as a result of tumour dedifferentiation.
Insights
Adrenocorticotrophin receptor (ACTH-R) mRNA expression differs in adrenal tumors. In benign tumors, ACTH-R mRNA correlates with P450scc mRNA, but this correlation is lost in carcinomas, suggesting dedifferentiation.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Adrenocorticotrophin (ACTH) regulates steroid secretion via the ACTH receptor (ACTH-R).
- Cloning of the ACTH-R enables study of its role in adrenal tumorigenesis.
- Investigating ACTH-R and P450 side-chain cleavage enzyme (P450scc) mRNA expression is crucial for understanding adrenal neoplasms.
Purpose of the Study:
- To investigate ACTH-R and P450scc mRNA expression in various neoplastic adrenocortical tissues.
- To determine the relationship between ACTH-R mRNA expression and plasma ACTH concentrations.
- To explore the correlation between ACTH-R and P450scc mRNA in normal and neoplastic adrenal tissues.
Main Methods:
- Analysis of mRNA expression using Northern blot and reverse-transcriptase-PCR (RT-PCR).
- Studied tissues included normal adrenals, hyperplasias, adenomas, carcinomas, and cell lines.
- Hybridization with radiolabeled human ACTH-R and P450scc cDNAs.
Main Results:
- Significant differences in ACTH-R mRNA expression were observed across tissue groups (P=0.0001).
- ACTH-R mRNA expression was low in non-functional adenomas and carcinomas, intermediate in hyperplasias and cortisol-producing adenomas, and high in aldosteronomas.
- A strong positive correlation between ACTH-R and P450scc mRNA was found in adenomas (r=0.8, P=0.0001) but not in carcinomas (r=-0.44, P=0.3).
Conclusions:
- Plasma ACTH levels do not significantly influence ACTH-receptor mRNA expression in neoplastic adrenal tissue.
- A positive correlation between ACTH-receptor mRNA and P450scc mRNA exists in benign adrenal tumors.
- The loss of this correlation in adrenocortical carcinomas likely indicates tumor dedifferentiation.
Related Concept Videos
Abnormal Proliferation
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology

